About Developmentally-regulated GTP-binding protein 2
Developmentally-regulated GTP-binding protein 2 (DRG2) is a protein
from Homo sapiens identified by UniProt accession
P55039, 364 residues long.
MolForge cross-references it against 0 known binders and
68 disease associations.
Target properties
| Protein name | Developmentally-regulated GTP-binding protein 2 |
| UniProt accession | P55039 |
| Gene | DRG2 |
| Organism | Homo sapiens |
| Length | 364 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (68)
Diseases linked to this target (Open Targets).
- sex hormone-binding globulin measurement · score 0.29
- neurodegenerative disease · score 0.24
- blood phosphate measurement · score 0.22
- insulin like growth factor measurement · score 0.12
- IGF-1 measurement · score 0.12
- BMI-adjusted hip circumference · score 0.10
- neoplasm · score 0.08
- BMI-adjusted waist-hip ratio · score 0.07
- cancer · score 0.07
- melanoma · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P55039-F1 | alphafold | PREDICTED | 84.71 | — |
Amino-acid sequence (364 residues)
MGILEKISEI EKEIARTQKN KATEYHLGLL KAKLAKYRAQ LLEPSKSASS KGEGFDVMKS GDARVALIGF PSVGKSTFLS LMTSTASEAA SYEFTTLTCI PGVIEYKGAN IQLLDLPGII EGAAQGKGRG RQVIAVARTA DVIIMMLDAT KGEVQRSLLE KELESVGIRL NKHKPNIYFK PKKGGGISFN STVTLTQCSE KLVQLILHEY KIFNAEVLFR EDCSPDEFID VIVGNRVYMP CLYVYNKIDQ ISMEEVDRLA RKPNSVVISC GMKLNLDYLL EMLWEYLALT CIYTKKRGQR PDFTDAIILR KGASVEHVCH RIHRSLASQF KYALVWGTST KYSPQRVGLT HTMEHEDVIQ IVKK
Explore Developmentally-regulated GTP-binding protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets